# FDA Guidance Document Concerning Use of Pilot Manufacturing Facilities for the Development and Manufacture of Biological Products - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/fda-guidance-document-concerning-use-of-pilot-manufacturing-facilities-for-the-development-and-manufacture-of-biological-products/d98f4363-07c5-4cc7-a8ff-82c072cb88b2 > FDA guidance document: FDA Guidance Document Concerning Use of Pilot Manufacturing Facilities for the Development and Manufacture of Biological Products. Issue date: July 11, 1995. Get complete insights and analysis. --- ## Details - Title: FDA Guidance Document Concerning Use of Pilot Manufacturing Facilities for the Development and Manufacture of Biological Products - Communication Type: Guidance Document - Product Type: biologics - Office Name: Center for Biologics Evaluation and Research - Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d - Issue Date: 1995-07-11 - Last Changed: 2024-07-26 - Docket Number: FDA-1995-D-0149 ## Related Documents - [Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/interacting-with-the-fda-on-complex-innovative-trial-designs-for-drugs-and-biological-products-guidance-for-industry/915195b1-fcb7-4359-b741-f4ca3ed67b13) - [Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization](https://www.globalkeysolutions.net/guidances/guidance-document/development-of-monoclonal-antibody-products-targeting-sars-cov-2-for-emergency-use-authorization/0146d188-0350-4f83-b103-4193b8be1e41) - [Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use](https://www.globalkeysolutions.net/guidances/guidance-document/points-to-consider-in-the-manufacture-and-testing-of-monoclonal-antibody-products-for-human-use/a46ecfe6-3346-4604-96dc-b32e5e663fff)